{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T13:22:11Z","timestamp":1794057731230,"version":"4.8.0"},"reference-count":65,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:p>Several COVID-19 vaccines have been developed and approved for use around the world from December 2020, to combat the pandemic caused by the novel SARS-CoV-2 virus. Several ophthalmic manifestations of the COVID-19 vaccines have been reported by ophthalmologists. This review was undertaken to recognize, encourage active reporting and determine the pathogenesis and time of appearance for better awareness and understanding of the ophthalmic manifestations of COVID-19 vaccines. A literature search was performed for publications on the ophthalmic manifestations of COVID-19 vaccines between January 1, 2021 and November 7, 2021. 23 case reports, 17 letters to editors, 3 ophthalmic images, 4 brief communications, 4 retrospective cohort studies and 2 case control studies were included. Posterior segment, including the uvea, choroid and retinal vasculature, was most commonly affected and the reported clinical features developed at a median of four days from the time of vaccination. The possible mechanisms include molecular mimicry of the vaccine components with host ocular tissues, antigen-specific cell and antibody-mediated hypersensitivity reactions to viral antigens and adjuvants present in the vaccines. The causal relationship of the ocular signs and symptoms and COVID-19 vaccines has not been established and requires long-term and large multicentre data. Most of the reported manifestations are mild, transient and adequately treated when diagnosed and managed early. The benefits of COVID-19 vaccination outweighs the reported rare adverse events and should not be a deterrent to vaccination.<\/jats:p>","DOI":"10.4103\/ijo.ijo_2824_21","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T06:54:59Z","timestamp":1638255299000},"page":"3398-3420","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":48,"title":["After the Storm: Ophthalmic Manifestations of COVID-19 Vaccines"],"prefix":"10.4103","volume":"69","author":[{"given":"Mrittika","family":"Sen","sequence":"first","affiliation":[{"name":"Ophthalmic and Facial Plastic Surgery and Ocular Oncology Service, Centre for Sight, Hyderabad, Telangana, India"},{"name":"Ocular Oncology Service, Wills Eye Hospital, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh G","family":"Honavar","sequence":"additional","affiliation":[{"name":"Ophthalmic and Facial Plastic Surgery and Ocular Oncology Service, Centre for Sight, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,11,26]]},"reference":[{"key":"B6-20240828","doi-asserted-by":"crossref","first-page":"488","DOI":"10.4103\/ijo.IJO_297_21","article-title":"COVID-19 and eye:A review of ophthalmic manifestations of COVID-19","volume":"69","author":"Sen","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"B7-20240828","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/IOP.0000000000002042","article-title":"Transient eyelid edema following COVID-19 vaccination","volume":"37","author":"Austria","year":"2021","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"B8-20240828","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.17340","article-title":"Purpuric lesions on the eyelids developed after BNT162b2 mRNA COVID-19 vaccine:Another piece of SARS-CoV-2 skin puzzle?","author":"Mazzatenta","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B9-20240828","article-title":"Corneal graft rejection following COVID-19 vaccine","author":"Rallis","year":"2021","journal-title":"Eye"},{"key":"B10-20240828","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/ICL.0000000000000840","article-title":"Bilateral EK rejection after COVID-19 vaccine","volume":"47","author":"Abousy","year":"2021","journal-title":"Eye Contact Lens"},{"key":"B11-20240828","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/bjophthalmol-2021-319338","article-title":"Characteristics of endothelial corneal transplant rejection following immunisation with SARS-CoV-2 messenger RNA vaccine","volume":"105","author":"Phylactou","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"B12-20240828","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/ICO.0000000000002761","article-title":"Keratoplasty rejection after the BNT162b2 messenger RNA vaccine","volume":"40","author":"Wasser","year":"2021","journal-title":"Cornea"},{"key":"B13-20240828","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.4103\/ijo.IJO_1028_21","article-title":"Corneal graft rejection after COVID-19 vaccination","volume":"69","author":"Ravichandran","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"B14-20240828","doi-asserted-by":"crossref","first-page":"e445","DOI":"10.1016\/j.jfo.2021.06.001","article-title":"Acute corneal endothelial graft rejection following COVID-19 vaccination","volume":"44","author":"Crnej","year":"2021","journal-title":"J Fr Ophtalmol"},{"key":"B15-20240828","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.4103\/ijo.IJO_2515_21","article-title":"Acute graft rejection in a high-risk corneal transplant following COVID -19 vaccination: A case report","volume":"69","author":"Parmar","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"B16-20240828","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1001\/jamaophthalmol.2021.3477","article-title":"Association of ocular adverse events with inactivated COVID-19 vaccination in patients in Abu Dhabi","volume":"139","author":"Pichi","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"B17-20240828","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/ICU.0000000000000530","article-title":"Drug-induced uveitis","volume":"29","author":"Moorthy","year":"2018","journal-title":"Curr Opin Ophthalmol"},{"key":"B18-20240828","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40942-021-00319-3","article-title":"Vogt-Koyanagi-Harada syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine","volume":"7","author":"Saraceno","year":"2021","journal-title":"Int J Retina Vitreous"},{"key":"B19-20240828","first-page":"1","article-title":"Vogt-Koyanagi-Harada disease associated with COVID-19 mRNA vaccine","author":"Koong","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"B20-20240828","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12348-021-00251-5","article-title":"Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, following anti-SARS-CoV-2 vaccination","volume":"11","author":"Papasavvas","year":"2021","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"B21-20240828","first-page":"1","article-title":"Acute uveitis following COVID-19 vaccination","author":"ElSheikh","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"B22-20240828","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.4103\/ijo.IJO_1435_21","article-title":"COVID-19 vaccine-associated reactivation of uveitis","volume":"69","author":"Jain","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"B23-20240828","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijid.2021.07.035","article-title":"Anterior uveitis onset after bnt162b2 vaccination:Is this just a coincidence?","volume":"110","author":"Renisi","year":"2021","journal-title":"Int J Infect Dis"},{"key":"B24-20240828","doi-asserted-by":"crossref","DOI":"10.1097\/IAE.0000000000003277","article-title":"Uveitis following the BNT162b2 mRNA vaccination against SARS-CoV-2 infection:A possible association","author":"Rabinovitch","year":"2021","journal-title":"Retina (Philadelphia, Pa.)"},{"key":"B25-20240828","doi-asserted-by":"crossref","first-page":"107970","DOI":"10.1016\/j.intimp.2021.107970","article-title":"Autoimmune phenomena following SARS-CoV-2 vaccination","volume":"99","author":"Ishay","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B26-20240828","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1080\/09273948.2021.1949478","article-title":"Panuveitis following vaccination for COVID-19","volume":"29","author":"Mudie","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"B27-20240828","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/09273948.2021.1957123","article-title":"Bilateral multifocal choroiditis following COVID-19 vaccination","volume":"29","author":"Goyal","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"B28-20240828","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijid.2021.09.075","article-title":"Bilateral uveitis after inoculation with COVID-19 vaccine:A case report","volume":"113","author":"Pan","year":"2021","journal-title":"Int J Infect Dis"},{"key":"B29-20240828","doi-asserted-by":"crossref","first-page":"101136","DOI":"10.1016\/j.ajoc.2021.101136","article-title":"Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine","volume":"23","author":"Fowler","year":"2021","journal-title":"Am J Ophthalmol Case Rep"},{"key":"B30-20240828","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1007\/s10792-021-01971-2","article-title":"Central retinal vein occlusion occurring immediately after 2nd dose of mRNA SARS-CoV-2 vaccine","volume":"41","author":"Bialasiewicz","year":"2021","journal-title":"Int Ophthalmol"},{"key":"B31-20240828","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.4103\/ijo.IJO_1477_21","article-title":"Central retinal vein occlusion after mRNA SARS-CoV-2 vaccination:A case report","volume":"69","author":"Endo","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"B32-20240828","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.4103\/ijo.IJO_2412_21","article-title":"Unilateral retinal vein occlusion in a young, healthy male following Sputnik V vaccination","volume":"69","author":"Goyal","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"B33-20240828","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1080\/09273948.2021.1946567","article-title":"Acute macular neuroretinopathy following coronavirus disease 2019 vaccination","volume":"29","author":"Mambretti","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"B34-20240828","article-title":"Acute macular neuroretinopathy following SARS-CoV-2 vaccination","author":"Patel","year":"2021","journal-title":"Retin Cases Brief Rep"},{"key":"B35-20240828","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.4103\/ijo.IJO_1333_21","article-title":"Bilateral paracentral acute middle maculopathy and acute macular neuroretinopathy following COVID-19 vaccination","volume":"69","author":"Vinzamuri","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"B36-20240828","doi-asserted-by":"crossref","first-page":"e212471","DOI":"10.1001\/jamaophthalmol.2021.2471","article-title":"Bilateral acute macular neuroretinopathy after vaccination against SARS-CoV-2","volume":"139","author":"Book","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"B37-20240828","doi-asserted-by":"crossref","first-page":"101200","DOI":"10.1016\/j.ajoc.2021.101200","article-title":"Acute macular neuroretinopathy following Pfizer-BioNTech COVID-19 vaccination","volume":"24","author":"Valenzuela","year":"2021","journal-title":"Am J Ophthalmol Case Rep"},{"key":"B38-20240828","doi-asserted-by":"crossref","first-page":"101207","DOI":"10.1016\/j.ajoc.2021.101207","article-title":"Acute macular neuroretinopathy (AMN) following COVID-19 vaccination","volume":"24","author":"Dr\u00fcke","year":"2021","journal-title":"Am J Ophthalmol Case Rep"},{"key":"B39-20240828","article-title":"Acute macular neuroretinopathy following COVID-19 vaccination [published online ahead of print, 2021 Jun 22]","volume":"1-2","author":"B\u00f8hler","year":"2021","journal-title":"Eye (Lond)"},{"key":"B40-20240828","doi-asserted-by":"crossref","DOI":"10.21203\/rs.3.rs-632137\/v1","article-title":"Acute macular neuroretinopathy after COVID-19 Vaccine","author":"Michel","year":"2021"},{"key":"B41-20240828","article-title":"Reactivation of varicella zoster infection presenting as acute retinal necrosis post COVID 19 vaccination in an Asian Indian male","author":"Mishra","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"B42-20240828","first-page":"490","article-title":"COVID-19 recombinant mRNA vaccines and serious ocular inflammatory side effects:Real or coincidence?","volume":"16","author":"Maleki","year":"2021","journal-title":"J Ophthalmic Vis Res"},{"key":"B43-20240828","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s11739-021-02685-0","article-title":"Deep vein thrombosis (DVT) occurring shortly after the second dose of mRNA SARS-CoV-2 vaccine","volume":"16","author":"Carli","year":"2021","journal-title":"Intern Emerg Med"},{"key":"B44-20240828","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/ajh.26132","article-title":"Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination","volume":"96","author":"Lee","year":"2021","journal-title":"Am J Hematol"},{"key":"B45-20240828","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.3928\/23258160-20181002-23","article-title":"Acute macular neuroretinopathy following the administration of an influenza vaccination","volume":"49","author":"Shah","year":"2018","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"B46-20240828","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ajoc.2018.02.008","article-title":"Acute macular neuroretinopathy associated with influenza vaccination with decreased flow at the deep capillary plexus on oct angiography","volume":"10","author":"Liu","year":"2018","journal-title":"Am J Ophthalmol Case Rep"},{"key":"B47-20240828","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3390\/vaccines9060572","article-title":"Reactivation of varicella zoster virus after vaccination for SARS-CoV-2","volume":"9","author":"Psichogiou","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"B48-20240828","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMe2106315","article-title":"SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia","volume":"384","author":"Cines","year":"2021","journal-title":"N Engl J Med"},{"key":"B49-20240828","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1001\/jamaophthalmol.2021.3483","article-title":"COVID-19, COVID-19 vaccinations, and subsequent abnormalities in the retina:Causation or coincidence?","volume":"139","author":"Jampol","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"B50-20240828","first-page":"1","article-title":"Acute thyroiditis and bilateral optic neuritis following SARS-CoV-2 vaccination with CoronaVac:A case report","author":"Leber","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"B51-20240828","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00011-021-01476-9","article-title":"Acute reduction of visual acuity and visual field after Pfizer-BioNTech COVID-19 vaccine 2nd dose:A case report","volume":"70","author":"Santovito","year":"2021","journal-title":"Inflamm Res"},{"key":"B52-20240828","doi-asserted-by":"crossref","first-page":"101212","DOI":"10.1016\/j.ajoc.2021.101212","article-title":"Transient visual field loss after COVID-19 vaccination:Experienced by ophthalmologist, case report","volume":"24","author":"Jumroendararasame","year":"2021","journal-title":"Am J Ophthalmol Case Rep"},{"key":"B53-20240828","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.4103\/ijo.IJO_2122_21","article-title":"Ophthalmic complications of COVID-19 vaccination","volume":"69","author":"Pawar","year":"2021","journal-title":"Indian J Ophthalmol"},{"issue":"21","key":"B54-20240828","first-page":"00109","article-title":"Acute abducens nerve palsy following COVID-19 vaccination","volume":"S1091-8531","author":"Reyes-Capo","year":"2021","journal-title":"J AAPOS"},{"key":"B55-20240828","article-title":"Transient Oculomotor Palsy Following the Administration of the Messenger RNA-1273 Vaccine for SARS-CoV-2 Diplopia Following the COVID-19 Vaccine","author":"Pappaterra","year":"2021","journal-title":"J Neuroophthalmol"},{"key":"B56-20240828","first-page":"143","article-title":"Peripheral facial nerve palsy following BNT162b2 (COVID-19) vaccination","volume":"23","author":"Shemer","year":"2021","journal-title":"Isr Med Assoc J"},{"key":"B57-20240828","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.4103\/ijo.IJO_1658_21","article-title":"Facial nerve palsy after COVID19 vaccination \u2013A rare association or a coincidence","volume":"69","author":"Ish","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"B58-20240828","doi-asserted-by":"crossref","first-page":"8274","DOI":"10.12998\/wjcc.v9.i27.8274","article-title":"Bell's palsy after inactivated COVID-19 vaccination in a patient with history of recurrent Bell's palsy:A case report","volume":"9","author":"Yu","year":"2021","journal-title":"World J Clin Cases"},{"key":"B59-20240828","article-title":"Ramsay Hunt syndrome following mRNA SARS-COV-2 vaccine","author":"Rodr\u00edguez-Mart\u00edn","year":"2021","journal-title":"Enferm Infecc Microbiol Clin (Engl Ed)"},{"key":"B60-20240828","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/jamaoto.2021.1259","article-title":"Association of COVID-19 vaccination and facial nerve palsy:A case-control study","volume":"147","author":"Shemer","year":"2021","journal-title":"JAMA Otolaryngology Head Neck Surg"},{"key":"B63-20240828","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S1473-3099(21)00076-1","article-title":"Bell's palsy and SARS-CoV-2 vaccines","volume":"21","author":"Ozonoff","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"B64-20240828","doi-asserted-by":"crossref","DOI":"10.1177\/25158163211044797","article-title":"Isolated intracranial hypertension following COVID-19 vaccination:A case report","volume":"4","author":"Thunstedt","year":"2021","journal-title":"Cephalalgia Reports"},{"key":"B65-20240828","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1097\/IOP.0000000000002059","article-title":"Thyroid eye disease following COVID-19 vaccine in a patient with a history Graves' disease:A case report","volume":"37","author":"Rubinstein","year":"2021","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"B66-20240828","first-page":"e16791","article-title":"Tolosa-Hunt syndrome presenting after COVID-19 vaccination","volume":"13","author":"Chuang","year":"2021","journal-title":"Cureus"},{"key":"B67-20240828","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/S0140-6736(21)00872-2","article-title":"Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"397","author":"Bayas","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"B68-20240828","doi-asserted-by":"crossref","first-page":"e2021048","DOI":"10.4084\/MJHID.2021.048","article-title":"A Rare Case of Superior Ophthalmic Vein Thrombosis and Thrombocytopenia Following ChAdOx1 nCoV-19 Vaccine Against SARS-CoV-2","volume":"13","author":"Panovska-Stavridis","year":"2021","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"10306","key":"B69-20240828","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(21)01608-1","article-title":"Cerebral venous thrombosis after vaccination against COVID-19 in the UK:a multicentre cohort study","volume":"398","author":"Perry","year":"2021","journal-title":"The Lancet"},{"key":"B70-20240828","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijid.2021.04.047","article-title":"Side effects of BNT162b2 mRNA COVID-19 vaccine:A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers","volume":"106","author":"Kadali","year":"2021","journal-title":"Int J Infect Dis"},{"key":"B71-20240828","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1002\/jmv.26996","article-title":"Non-life-threatening adverse effects with COVID-19 mRNA-1273 vaccine:A randomized, cross sectional study on healthcare workers with detailed self-reported symptoms","volume":"93","author":"Kadali","year":"2021","journal-title":"J Med Virol"},{"key":"B72-20240828","first-page":"1","article-title":"Ocular adverse events after COVID-19 vaccination","author":"Ng","year":"2021","journal-title":"Ocul Immunol Inflamm"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_2824_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:16:40Z","timestamp":1787167000000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_2824_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,26]]},"references-count":65,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_2824_21","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,26]]},"assertion":[{"value":"2021-11-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}